皮膚炎の世界市場レポート 2025年

皮膚炎の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR5.0％で86億6,000万米ドルに成長します。予測期間の成長は、患者の意識の高まり、環境要因に起因すると考えられます。予測期間の主な動向には、研究開発、遠隔医療とデジタルヘルス、生物製剤と標的療法、個別化医療などが含まれます。

皮膚炎市場の成長は、主に世界の有病率の増加に起因しています。皮膚炎の有病率は、小児で約15～20％、成人で1～3％と推定されています。食物アレルギーの罹患率の上昇が皮膚炎の有病率に寄与しており、この症状を治療する医薬品の需要増につながっています。例えば、2022年10月に国際湿疹協議会（IEC）が発表したGlobal Atopic皮膚炎Atlas（GADA）によると、2022年には約2億2,300万人がアトピー皮膚炎に罹患し、そのうち約4,300万人が1～4歳の年齢層であると報告されています。

世界の老人人口の増加は、皮膚炎市場の成長を促進すると予想されています。脂漏性皮膚炎や接触性皮膚炎などの特定のタイプの皮膚炎は、加齢に伴う皮膚の変化によって高齢者に多く見られ、皮膚刺激物やアレルゲンの影響を受けやすくなっています。このため皮膚炎市場は、高齢者の皮膚科的悩みに対応する専門的ソリューションを開発する機会を得ています。例えば、2022年10月の世界保健機関（WHO）によると、60歳以上の世界人口は2020年の10億人から2022年には14億人に増加すると予測されています。2030年には、世界の6人に1人が60歳以上となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界皮膚炎PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の皮膚炎市場：成長率分析
• 世界の皮膚炎市場の実績：規模と成長, 2019-2024
• 世界の皮膚炎市場の予測：規模と成長, 2024-2029, 2034F
• 世界皮膚炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の皮膚炎市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• エモリエント剤と保湿剤
• 抗ヒスタミン薬
• カルシニューリン阻害剤
• 抗生物質
• 免疫調節薬
• インターロイキン阻害剤
• 世界の皮膚炎市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 小売薬局
• ドラッグストア
• オンラインまたは郵送薬局
• 世界の皮膚炎市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん
• 血液疾患
• 慢性疾患
• 感染症
• 世界の皮膚炎市場コルチコステロイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所コルチコステロイド
• 経口コルチコステロイド
• 注射用コルチコステロイド
• 世界の皮膚炎市場、エモリエント剤または保湿剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリーム
• 軟膏
• ローション
• ゲル
• その他のエモリエント剤または保湿剤
• 世界の皮膚炎市場抗ヒスタミン薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口抗ヒスタミン薬
• 局所抗ヒスタミン薬
• 注射用抗ヒスタミン薬
• 世界の皮膚炎市場カルシニューリン阻害剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所カルシニューリン阻害剤（タクロリムス、ピメクロリムス）
• 経口カルシニューリン阻害剤
• 世界の皮膚炎市場抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所抗生物質
• 経口抗生物質
• 全身抗生物質
• 世界の皮膚炎市場免疫調節剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所免疫調節薬
• 経口免疫調節薬
• 世界の皮膚炎市場インターロイキン阻害剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• IL-4阻害剤
• IL-13阻害剤
• IL-31阻害剤
• その他のインターロイキン阻害剤

第7章 地域別・国別分析

• 世界の皮膚炎市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の皮膚炎市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 皮膚炎市場：競合情勢
• 皮膚炎市場：企業プロファイル
  • LEO Pharma AS Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Encore Dermatology Inc.
• Meda Pharmaceuticals Inc.
• Allergan Plc
• Bristol-Myers Squibb Co.
• Anacor Pharmaceutical Inc.
• Astellas Pharma Inc.
• Mylan N.V.
• Valeant Pharmaceutical Inc.
• Galderma SA
• Dow Inc.
• Connetics Corporation
• Fujisawa Pharmaceutical Company Ltd.
• AbbVie Inc.
• F. Hoffmann-La Roche Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 皮膚炎市場2029：新たな機会を提供する国
• 皮膚炎市場2029：新たな機会を提供するセグメント
• 皮膚炎市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Dermatitis refers to treatments designed to alleviate skin inflammation, typically characterized by itchy rashes on the swollen and reddened outer layer of the skin. This is a broad term that encompasses various common skin irritations.

The primary categories of drugs used to manage dermatitis include corticosteroids, emollients/moisturizers, antihistamines, calcineurin inhibitors, antibiotics, immunomodulators, and interleukin inhibitors. Corticosteroids are a group of steroid hormones produced by the adrenal cortex in vertebrates, and synthetic versions of these hormones are also used. These drugs can be administered through different routes, such as topical (applied to the skin), oral (taken by mouth), and injectable (administered by injection), and they find applications in the treatment of conditions like cancer, blood disorders, chronic diseases, and infectious diseases. Dermatitis treatments are available through various channels, including hospitals, retail pharmacies, drug stores, as well as online or mail-order pharmacies.

The dermatitis market research report is one of a series of new reports from The Business Research Company that provides dermatitis market statistics, including dermatitis industry global market size, regional shares, competitors with a dermatitis market share, detailed dermatitis market segments, market trends, and opportunities, and any further data you may need to thrive in the dermatitis industry. This dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dermatitis market size has grown strongly in recent years. It will grow from $6.77 billion in 2024 to $7.13 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increased prevalence, diagnostic advancements, treatment options, regulatory approvals.

The dermatitis market size is expected to see steady growth in the next few years. It will grow to $8.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to growing patient awareness, environmental factors. Major trends in the forecast period include research and development, telemedicine and digital health, biologics and targeted therapies, personalized medicine.

The growth of the dermatitis market is primarily attributed to the increasing global prevalence of the disease. The prevalence of dermatitis is estimated to be around 15-20% in children and 1-3% in adults. The rising incidence of food allergies is contributing to the prevalence of dermatitis, leading to a higher demand for medications to treat this condition. For instance, in October 2022, the Global Atopic Dermatitis Atlas (GADA), published by the International Eczema Council (IEC), reported approximately 223 million individuals affected by atopic dermatitis in 2022, with around 43 million in the age group of 1 to 4 years.

The rise in the global geriatric population is expected to drive the growth of the dermatitis market. Certain types of dermatitis, such as seborrheic and contact dermatitis, are more common in the elderly due to age-related changes in the skin, making them more susceptible to skin irritants and allergens. This creates an opportunity for the dermatitis market to develop specialized solutions to address the dermatological concerns of the aging population. For example, according to the World Health Organization in October 2022, the global population of individuals aged 60 years and older is projected to increase to 1.4 billion by 2022, compared to 1 billion in 2020. By 2030, one out of every six people in the world will be aged 60 years or older.

The dermatitis market has seen a trend of increasing mergers and acquisitions (M&As), aimed at business expansion and increased market visibility. Vendors in the industry are focusing on collaborations and partnerships to enhance their portfolios and market presence. M&As are strategic moves to reduce competition and increase business scalability. For instance, in March 2022, Pfizer Inc. acquired Arena Pharmaceuticals, Inc., a clinical-stage company developing treatments for dermatology diseases, including atopic dermatitis (AD). This acquisition strengthens Pfizer's portfolio of therapeutic candidates in fields like gastroenterology, dermatology, and cardiology.

Major companies in the dermatitis market are introducing innovative, clean-label, steroid-free products like ARCTIVA to gain a competitive edge and enhance their product offerings. ARCTIVA is a range of steroid-free skincare products designed to treat skin conditions such as eczema and psoriasis, featuring advanced Hydrosurf Glycolipid Technology. In April 2023, Arctiva Wellness, LLC introduced ARCTIVA, which combines scientific research with natural, cruelty-free ingredients and clinically validated, FDA-approved active components to deliver proven results. It is the exclusive product line featuring the revolutionary Hydrosurf Glycolipid Technology, originally discovered in Antarctica.

Major companies operating in the dermatitis market include LEO Pharma AS, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Bayer AG, Encore Dermatology Inc., Meda Pharmaceuticals Inc., Allergan PLC, Bristol-Myers Squibb Co., Anacor Pharmaceutical Inc., Astellas Pharma Inc., Mylan N.V., Valeant Pharmaceutical Inc., Galderma SA, Dow Inc., Connetics Corporation, Fujisawa Pharmaceutical Company Ltd., AbbVie Inc., F. Hoffmann-La Roche Ltd., Valeant Pharmaceuticals International Inc., GlaxoSmithKline PLC, Medimmune Inc., Bausch Health Co. Inc., Nestle Skin Health India Pvt. Ltd., Aqua Pharmaceuticals Pvt. Ltd., C.H. Boehringer Sohn AG & Co. KG, Biofrontera AG, Zydus Lifesciences Limited

North America was the largest region in the dermatitis market in 2024. Middle East is expected to be the fastest-growing region in the dermatitis market report during the forecast period. The regions covered in the dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The dermatitis market consists of sales of Stasis dermatitis, atopic dermatitis, and irritant contact dermatitis. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dermatitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dermatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dermatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dermatitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Corticosteroids; Emollients Or Moisturizers; Antihistamines; Calcineurin Inhibitors; Antibiotics; Immunomodulators; Interleukin Inhibitors
• 2) By Distribution Channel: Hospital; Retail Pharmacies; Drug Stores; Online Or Mail Pharmacies
• 3) By Application: Cancer; Blood Disorders; Chronic Diseases; Infectious Diseases
• Subsegments:
• 1) By Corticosteroids: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids
• 2) By Emollients Or Moisturizers: Creams; Ointments; Lotions; Gels; Other Emollients Or Moisturizers
• 3) By Antihistamines: Oral Antihistamines; Topical Antihistamines; Injectable Antihistamines
• 4) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors (Tacrolimus, Pimecrolimus); Oral Calcineurin Inhibitors
• 5) By Antibiotics: Topical Antibiotics; Oral Antibiotics; Systemic Antibiotics
• 6) By Immunomodulators: Topical Immunomodulators; Oral Immunomodulators
• 7) By Interleukin Inhibitors: IL-4 Inhibitors; IL-13 Inhibitors; IL-31 Inhibitors; Other Interleukin Inhibitors
• Companies Mentioned: LEO Pharma AS; Novartis AG; Pfizer Inc.; Regeneron Pharmaceuticals Inc.; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dermatitis Market Characteristics

3. Dermatitis Market Trends And Strategies

4. Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Dermatitis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dermatitis Market Growth Rate Analysis
• 5.4. Global Dermatitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dermatitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dermatitis Total Addressable Market (TAM)

6. Dermatitis Market Segmentation

• 6.1. Global Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Emollients and Moisturizers
• Antihistamines
• Calcineurin Inhibitors
• Antibiotics
• Immunomodulators
• Interleukin Inhibitors
• 6.2. Global Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Retail Pharmacies
• Drug Stores
• Online Or Mail Pharmacies
• 6.3. Global Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Blood Disorders
• Chronic Diseases
• Infectious Diseases
• 6.4. Global Dermatitis Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Corticosteroids
• Oral Corticosteroids
• Injectable Corticosteroids
• 6.5. Global Dermatitis Market, Sub-Segmentation Of Emollients Or Moisturizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Creams
• Ointments
• Lotions
• Gels
• Other Emollients Or Moisturizers
• 6.6. Global Dermatitis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Antihistamines
• Topical Antihistamines
• Injectable Antihistamines
• 6.7. Global Dermatitis Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Calcineurin Inhibitors (Tacrolimus, Pimecrolimus)
• Oral Calcineurin Inhibitors
• 6.8. Global Dermatitis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Antibiotics
• Oral Antibiotics
• Systemic Antibiotics
• 6.9. Global Dermatitis Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Immunomodulators
• Oral Immunomodulators
• 6.10. Global Dermatitis Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• IL-4 Inhibitors
• IL-13 Inhibitors
• IL-31 Inhibitors
• Other Interleukin Inhibitors

7. Dermatitis Market Regional And Country Analysis

• 7.1. Global Dermatitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dermatitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dermatitis Market

• 8.1. Asia-Pacific Dermatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dermatitis Market

• 9.1. China Dermatitis Market Overview
• 9.2. China Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dermatitis Market

• 10.1. India Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dermatitis Market

• 11.1. Japan Dermatitis Market Overview
• 11.2. Japan Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dermatitis Market

• 12.1. Australia Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dermatitis Market

• 13.1. Indonesia Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dermatitis Market

• 14.1. South Korea Dermatitis Market Overview
• 14.2. South Korea Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dermatitis Market

• 15.1. Western Europe Dermatitis Market Overview
• 15.2. Western Europe Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dermatitis Market

• 16.1. UK Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dermatitis Market

• 17.1. Germany Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dermatitis Market

• 18.1. France Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dermatitis Market

• 19.1. Italy Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dermatitis Market

• 20.1. Spain Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dermatitis Market

• 21.1. Eastern Europe Dermatitis Market Overview
• 21.2. Eastern Europe Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dermatitis Market

• 22.1. Russia Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dermatitis Market

• 23.1. North America Dermatitis Market Overview
• 23.2. North America Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dermatitis Market

• 24.1. USA Dermatitis Market Overview
• 24.2. USA Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dermatitis Market

• 25.1. Canada Dermatitis Market Overview
• 25.2. Canada Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dermatitis Market

• 26.1. South America Dermatitis Market Overview
• 26.2. South America Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dermatitis Market

• 27.1. Brazil Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dermatitis Market

• 28.1. Middle East Dermatitis Market Overview
• 28.2. Middle East Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dermatitis Market

• 29.1. Africa Dermatitis Market Overview
• 29.2. Africa Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dermatitis Market Competitive Landscape And Company Profiles

• 30.1. Dermatitis Market Competitive Landscape
• 30.2. Dermatitis Market Company Profiles
  • 30.2.1. LEO Pharma AS Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Dermatitis Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Encore Dermatology Inc.
• 31.3. Meda Pharmaceuticals Inc.
• 31.4. Allergan Plc
• 31.5. Bristol-Myers Squibb Co.
• 31.6. Anacor Pharmaceutical Inc.
• 31.7. Astellas Pharma Inc.
• 31.8. Mylan N.V.
• 31.9. Valeant Pharmaceutical Inc.
• 31.10. Galderma SA
• 31.11. Dow Inc.
• 31.12. Connetics Corporation
• 31.13. Fujisawa Pharmaceutical Company Ltd.
• 31.14. AbbVie Inc.
• 31.15. F. Hoffmann-La Roche Ltd.

32. Global Dermatitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dermatitis Market

34. Recent Developments In The Dermatitis Market

35. Dermatitis Market High Potential Countries, Segments and Strategies

• 35.1 Dermatitis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dermatitis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dermatitis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer